Genetics and epigenetics

Classical Ehlers-Danlos syndrome is genotypically and phenotypically complex – so how can we help patients find answers?

Do you know how to choose the right panel size when providing NGS testing for cancer patients?

Robert Dunn shares life as a biomedical scientist involved in cytogenetics for blood disorder diagnosis and treatment

NSCLC biomarker testing can be valuable for both patient and pathologist

Epigenetic testing could identify those at risk of preterm birth

Microsatellite instability testing can provide important diagnostic and therapeutic guidance for oncologists – but what is the best method?

Rapid, efficient, and easy oncology biomarker sequencing through NGS

With comprehensive genomic profiling, are we moving closer to personalized therapy for all cancer patients?

Could genetic testing put an end to heart disease once and for all?

Keeping next-generation sequencing in house has many benefits for both laboratories and patients